Legal & General Group
NTGN

Legal & General Group’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Legal & General Group’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,691
Closed -$4K – 3554
2020
Q1 		$4K Sell
1,691
-936
-36% -$1.53K ﹤0.01% 3303
2019
Q4 		$3K Hold
2,627
– – ﹤0.01% 3360
2019
Q3 		$5K Hold
2,627
– – ﹤0.01% 3331
2019
Q2 		$12K Hold
2,627
– – ﹤0.01% 3338
2019
Q1 		$17K Buy
2,627
+1,603
+157% +$8.39K ﹤0.01% 3148
2018
Q4 		$5K Hold
1,024
– – ﹤0.01% 3345
2018
Q3 		$9K Buy
+1,024
New +$11.3K ﹤0.01% 3338

Legal & General Group's NTGN Position: Q2 2020 in Review

Legal & General Group sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 1,691 shares — an estimated $4K sold.

Legal & General Group first reported a position in NTGN in Q3 2018 and held it in 7 quarters. The position peaked at $17K in Q1 2019. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

  • Legal & General Group reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Legal & General Group sold 1,691 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $4K.
  • Legal & General Group first reported a position in Neon Therapeutics, Inc. Common Stock in Q3 2018 and held it in 7 quarters.
  • Legal & General Group's Neon Therapeutics, Inc. Common Stock position peaked at $17K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Legal & General Group's 13F filing for Q2 2020, filed 14 Aug 2020.